Compare Prologis Inc (PLD) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prologis Inc vs Tilray Brands Inc — how do they compare? Prologis Inc trades at $136.97 (market cap $131.60B), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: Prologis Inc is far larger — about 222.4× Tilray Brands Inc's market cap, and Prologis Inc pays a 3.09% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| PLD | TLRY | |
|---|---|---|
Market Cap | $131.60B | $591.60M |
Sector | Real Estate | Health |
52-Week High | $149.96 | $21.00 |
52-Week Low | $110.98 | $3.88 |
Enterprise Value | $166.34B | $758.73M |
Dividend Yield | 3.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Prologis (PLD) trades at $138.49, up 0.84% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.13 exceeding the $0.747 estimate. Revenue grew to $8.79 billion in 2025, though net income margin dipped to 37.86%. The stock faces headwinds from a high P/E of 30.84 and rising debt-to-asset ratio, now at 37.2% for 2025. Recent news highlights institutional buying interest amid market volatility.
The outlook for PLD is mixed, with analyst consensus bullish (59.52% buy ratings) and a $160.13 price target suggesting 15.6% upside. Key opportunities include sustained revenue growth and dividend stability, but risks involve elevated valuation, debt levels, and macroeconomic sensitivity. The stock's performance hinges on Q3 2026 earnings and the integration of the SEGRO acquisition.
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
